Abstract:npg Systemic lupus erythematosus (SLE) is a typical autoimmune disease involving multiple systems and organs. Ample evidence suggests that autoreactive T cells play a pivotal role in the development of this autoimmune disorder. This study was undertaken to investigate the mechanisms of interaction between antigen presenting cells (APCs) and an autoreactive T cell (ATL1) clone obtained from lupus-prone BXSB mice. ATL1 cells, either before or after γ-ray irradiation, were able to activate naive B cells, as deter… Show more
“…Upon activation by self-antigens, cDC can promote lupus development by interacting with T cells and B cells. While in vivo studies of how cDC affect autoreactive T cells are still lacking, in vitro evidence suggests that moDC derived from the bone marrow of lupus mice or from PBMC of SLE patients, upon activation, can promote T cell activation and hamper Treg response [ 39 , 52 , 78 – 80 ]. It is demonstrated in both mouse and human cell studies that moDC activated by apoptotic cells or cytosolic dsDNA could induce the activation of T cells, including that of autoreactive T cells [ 52 , 79 ].…”
Section: Breakdown Of Immune Tolerance To Self In Sle By Cdcmentioning
confidence: 99%
“…It is demonstrated in both mouse and human cell studies that moDC activated by apoptotic cells or cytosolic dsDNA could induce the activation of T cells, including that of autoreactive T cells [ 52 , 79 ]. In addition, compared to bone marrow-derived macrophages, bone marrow-derived cDC (BMDC) from lupus-prone mice possessed higher ability to activate autoreactive T cells, suggesting that cDC rather than macrophages are the APC for autoreactive T cell activation [ 78 ]. Moreover, in vitro generated tolerogenic BMDC from SLE patients were less capable of generating Treg cells in vitro than HC BMDC [ 80 ].…”
Section: Breakdown Of Immune Tolerance To Self In Sle By Cdcmentioning
Dendritic cells (DC) play an important role in the pathogenesis of systemic lupus erythematosus (SLE), an autoimmune disease with multiple tissue manifestations. In this review, we summarize recent studies on the roles of conventional DC and plasmacytoid DC in the development of both murine lupus and human SLE. In the past decade, studies using selective DC depletions have demonstrated critical roles of DC in lupus progression. Comprehensive in vitro and in vivo studies suggest activation of DC by self-antigens in lupus pathogenesis, followed by breakdown of immune tolerance to self. Potential treatment strategies targeting DC have been developed. However, many questions remain regarding the mechanisms by which DC modulate lupus pathogenesis that require further investigations.
“…Upon activation by self-antigens, cDC can promote lupus development by interacting with T cells and B cells. While in vivo studies of how cDC affect autoreactive T cells are still lacking, in vitro evidence suggests that moDC derived from the bone marrow of lupus mice or from PBMC of SLE patients, upon activation, can promote T cell activation and hamper Treg response [ 39 , 52 , 78 – 80 ]. It is demonstrated in both mouse and human cell studies that moDC activated by apoptotic cells or cytosolic dsDNA could induce the activation of T cells, including that of autoreactive T cells [ 52 , 79 ].…”
Section: Breakdown Of Immune Tolerance To Self In Sle By Cdcmentioning
confidence: 99%
“…It is demonstrated in both mouse and human cell studies that moDC activated by apoptotic cells or cytosolic dsDNA could induce the activation of T cells, including that of autoreactive T cells [ 52 , 79 ]. In addition, compared to bone marrow-derived macrophages, bone marrow-derived cDC (BMDC) from lupus-prone mice possessed higher ability to activate autoreactive T cells, suggesting that cDC rather than macrophages are the APC for autoreactive T cell activation [ 78 ]. Moreover, in vitro generated tolerogenic BMDC from SLE patients were less capable of generating Treg cells in vitro than HC BMDC [ 80 ].…”
Section: Breakdown Of Immune Tolerance To Self In Sle By Cdcmentioning
Dendritic cells (DC) play an important role in the pathogenesis of systemic lupus erythematosus (SLE), an autoimmune disease with multiple tissue manifestations. In this review, we summarize recent studies on the roles of conventional DC and plasmacytoid DC in the development of both murine lupus and human SLE. In the past decade, studies using selective DC depletions have demonstrated critical roles of DC in lupus progression. Comprehensive in vitro and in vivo studies suggest activation of DC by self-antigens in lupus pathogenesis, followed by breakdown of immune tolerance to self. Potential treatment strategies targeting DC have been developed. However, many questions remain regarding the mechanisms by which DC modulate lupus pathogenesis that require further investigations.
“…A previous study has suggested that FasL + B cells and FasL + CD4 CD8 double negative (DN) T cells may contribute to the cytotoxic destruction of Fas + tissues in MRL/lpr mice [3] . In addition, most studies have reported that the hyper-interaction between T lymphocytes and B lymphocytes is involved [4] . Moreover, B cell hyperactivity and spontaneous antibody production have been reported in SLE.…”
Prednisone treatment restricts B lymphocyte differentiation into plasma cells in MRL/lpr mice, which may be correlated with the inhibition of IL-21 production and the restoration of the balance between Blimp-1 and Bcl-6.
“…[17][18][19] Aging BXSB males developed progressive monocytosis, more pronounced in the peripheral blood than in spleen. 20,21 Although monocytosis itself is inadequate to drive the disease process, 22 progression of renal pathology can be accelerated by systemic exposure of mice to lipopolysaccharide (LPS). 23 The exact role of monocytosis in BXSB remains poorly understood, and it is not clear whether it involves impairment of the functional properties of monocytes.…”
We present long-term outcomes of BXSB mice after non-myeloablative bone marrow transplants using major histocompatability complex (MHC)-matched cells. Groups differed in sources of donor lymphocytes or mesenchymal stromal cells (MSC). Unfractionated marrow cells from green fluorescent protein (GFP) transgenic (Tg) mice (BMT group) or from RAG1-/- B6 mice (RAG group) were injected intravenously (i.v.) into irradiated (550 cGy) hosts. As a source of mesenchymal cells, bone chips from GFP-Tg were injected intraperitoneally alone (MSC group) or along with i.v. bone marrow cells (BMT + MSC group). Controls were untreated mice (UnTx) or mice exposed to radiation only (Rad Cont). At 62 weeks post-transplant, surviving mice were harvested for histopathology, flow cytometry and real time polymerase chain reaction (RT-PCR). The mice from BMT + MSC group had the best outcomes for survival rates (71.4% vs. 43.8%), renal scores (2.9% vs. 28.8% glomerular sclerosis) and percent splenic monocytes (4.2 vs. 11.3%) compared with mice from Rad Cont. Improvement in RAG and BMT groups was less prominent but were comparable with one another. Although MSC alone were not sufficient to control the renal pathology, it limited the expansion of CD4(-)CD8(-) T cell populations without a change in Foxp3 expression. The results suggest the importance of the innate immune system in disease pathogenesis and a role for MSC in immunomodulation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.